Frontier Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Frontier Capital Management's JAZZ Position: Q2 2026 in Review
Frontier Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 46% in Q2 2026, selling an estimated $52.6M and leaving 277,279 shares worth $66.8M. The position accounts for 0.62% of the portfolio, ranked #38.
Frontier Capital Management first reported a position in JAZZ in Q2 2022 and has held it in 17 quarters since. The position peaked at $97.8M in Q1 2026. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Frontier Capital Management held 277,279 shares of Jazz Pharmaceuticals worth $66.8M as of Q2 2026.
- Frontier Capital Management sold 240,005 Jazz Pharmaceuticals shares in Q2 2026, an estimated $52.6M.
- Jazz Pharmaceuticals made up 0.62% of Frontier Capital Management's portfolio in Q2 2026, its #38 holding.
- Frontier Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
- Frontier Capital Management's Jazz Pharmaceuticals position peaked at $97.8M in Q1 2026.
- 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Frontier Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.